|
Daxor Corporation (DXR) DCF -Bewertung |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Daxor Corporation (DXR) Bundle
Möchten Sie den inneren Wert der Daxor Corporation bewerten? Unser DXR DCF-Taschenrechner integriert reale Daten mit umfassenden Anpassungsfunktionen, sodass Sie Ihre Prognosen verfeinern und Ihre Investitionsentscheidungen verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -1.0 | 5.8 | 6.3 | .2 | 2.1 | 1.7 | 1.3 | 1.0 | .8 | .6 |
| Revenue Growth, % | 0 | -684.28 | 8.4 | -97.41 | 1203.92 | -22.25 | -22.25 | -22.25 | -22.25 | -22.25 |
| EBITDA | -1.7 | 4.7 | 5.3 | .3 | .0 | 1.2 | .9 | .7 | .6 | .4 |
| EBITDA, % | 172.87 | 81.57 | 83.21 | 201.77 | 0 | 72.95 | 72.95 | 72.95 | 72.95 | 72.95 |
| Depreciation | .3 | .7 | .9 | .5 | .0 | .3 | .2 | .2 | .1 | .1 |
| Depreciation, % | -33.92 | 12.81 | 13.62 | 310.13 | 0 | 18.5 | 18.5 | 18.5 | 18.5 | 18.5 |
| EBIT | -2.1 | 4.0 | 4.4 | -.2 | .0 | .5 | .4 | .3 | .2 | .2 |
| EBIT, % | 206.79 | 68.76 | 69.58 | -108.35 | 0 | 27.67 | 27.67 | 27.67 | 27.67 | 27.67 |
| Total Cash | .6 | .7 | .0 | .0 | .0 | -.2 | -.1 | -.1 | -.1 | -.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | -2.94 | 0.52738 | 0.27309 | 8.69 | 0.45418 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | -8.03 | 1.5 | 0.98943 | 0 | 0 | -1.11 | -1.11 | -1.11 | -1.11 | -1.11 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -2.0 | 4.0 | 4.4 | -.2 | .0 | .5 | .4 | .3 | .2 | .2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1.6 | 4.8 | 5.2 | .3 | .0 | .7 | .6 | .5 | .4 | .3 |
| WACC, % | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 2.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 9 | |||||||||
| Present Terminal Value | 7 | |||||||||
| Enterprise Value | 9 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | 9 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | 1.95 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real DXR financials.
- Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Daxor Corporation’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life DXR Financials: Pre-filled historical and projected data for Daxor Corporation (DXR).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Daxor’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Daxor’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring Daxor Corporation’s (DXR) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including Daxor Corporation’s (DXR) intrinsic value.
- Step 5: Utilize the outputs to make informed investment decisions or generate detailed reports.
Why Choose Daxor Corporation (DXR)?
- Innovative Solutions: Benefit from cutting-edge technology tailored for the healthcare industry.
- Proven Results: Our products have consistently demonstrated improved patient outcomes.
- Expert Support: Access to a dedicated team of professionals ready to assist you.
- Comprehensive Data: Leverage extensive research and analytics to inform your decisions.
- Industry Leader: Trusted by healthcare providers and institutions worldwide.
Who Should Use Daxor Corporation (DXR)?
- Healthcare Professionals: Understand the implications of blood volume measurement and its impact on patient care.
- Researchers: Integrate advanced blood volume analysis into clinical studies or academic projects.
- Investors: Evaluate the potential of Daxor Corporation (DXR) by analyzing market trends and company performance.
- Medical Analysts: Enhance your analysis with a comprehensive understanding of Daxor's innovative technologies.
- Hospital Administrators: Discover how Daxor's solutions can improve operational efficiencies and patient outcomes.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Daxor Corporation (DXR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Daxor Corporation (DXR).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.